NCT03366064View on ClinicalTrials.gov

Haploidentical NK Cells After Pemetrexed in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

November 9, 2017

Primary Completion Date

September 3, 2018

Study Completion Date

June 15, 2019

Conditions
Non-small Cell Lung Cancer
Interventions
BIOLOGICAL

Pemetrexed and donor-derived NK cell infusion

Patients are administered with donor-derived NK cells one week after pemetrexed infusion

Trial Locations (1)

138-736

Asan Medical Center - University of Ulsan College of Medicine, Seoul

Sponsors
All Listed Sponsors
collaborator

Korea Research Institute of Bioscience & Biotechnology

OTHER_GOV

lead

Asan Medical Center

OTHER

NCT03366064 - Haploidentical NK Cells After Pemetrexed in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter